NCT01429350View on ClinicalTrials.gov

Assess the Penumbra System in the Treatment of Acute Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Ischemic Stroke
Interventions
DRUG

intravenous (IV) recombinant human tissue plasminogen activator (rtPA)

0.9mg/kg to a maximum of 90mg

DEVICE

Penumbra System

The Penumbra System is an aspiration based mechanical thrombectomy device

Trial Locations (4)

32610

Department of Neurological Surgery, Gainesville

53226

Medical College of Wisconsin, Milwaukee

60612

Neurosurgery, Rush University Medical Center, Chicago

80112

Endovascular Surgical Neuroradiology, Swedish Medical Center, Denver

Sponsors

Lead Sponsor

Penumbra Inc.
All Listed Sponsors
lead

Penumbra Inc.

INDUSTRY

NCT01429350 - Assess the Penumbra System in the Treatment of Acute Stroke | Biotech Hunter | Biotech Hunter